Sharehope Medicine Co., Ltd. · TPEX:8403
Sharehope Medicine — Q3 2025 Earnings Presentation
18 slides from Sharehope Medicine's earnings presentation, Nov 19, 2025
Slide 1: 2025 / Q4 Investor Conference Presentation
股票代號：8403 2025 / Q4 Investor Conference Presentation Presenter : Vincent Ho Spokesperson 2025.11.19
Slide 2: Outline
Outline 01. Summary of Operations 02. Financial Analysis 03. Missioncare 50 Healthy Taiwan 2
Slide 3: 01. Summary of Operations
EF RATAK i RR ABR Missioncare Ree ee 01. Summary of Operations Mesdece HERR Bassas Mase «= BRR Rareltee i 2 Oy peteeme
Slide 4: Taiwan locations of group facilities
TAIPEI © 18 82 2 x1 © FEHR x43 Baise HSINCHU = 4 eA AT Ah © eR x4 ib MIAOLI am) © ARES © BBE x2 TAICHUNG e ZE8m © 2H x8 TAINAN a © IBTBR x2 TAOYUAN @ BY BEBE x3 © BE fe x13 ome Re eo RRA CHR SRRELPL esBRS RRR © RB RBUSR CHANGHUA == / © eR x2 YUNLIN © Tes x1 CHIAYI LP © MBA x1 : KAOHSIUNG Bit | © (ER
Slide 5: Highlights of the 2025 business plan
Highlights of the 2025 business plan. Continue restructuring the operations and integrating the performance of subsidiaries. The core business is developing steadily, with the medical sector growing increasingly robust. Strengthen the professional capabilities and overall management efficiency
Slide 6: Leading a New Chapter in Healthy Taiwan: ShareHope Comprehensive Strategy
Leading a New Chapter in Healthy Taiwan: ShareHope Comprehensive Strategy 健康台灣 Enhancing Indigenous Health Services Telemedicine Consultations, Health Education Health Promotion and Chronic Resources in Native Languages Disease Prevention Comprehensive Enhancement of Pediatric Personalized Health Sc
Slide 7: 02. Financial Analysis
WEFRATAK BHABHA 02. Financial Analysis Mesias: HIGR@E Menems Mamma ee smarelie = MA @Qvvecmsn Dy eee
Slide 8: Consolidated Revenue in the past 3 years
Consolidated Revenue in the past 3 years Unit: thousand Consolidated Revenue 5,000,000 4,500,000 4,000,000 3,500,000 3,000,000 2023年 2,500,000 2,000,000 2024年 1,500,000 2025年前三季 1,000,000 500,000 0 營業收入 Total 2023 3,873,384 2024 4,325,831 2025Q1-Q3 3,231,727 8
Slide 9: Net income in the past 3 years
Net income in the past 3 years Unit: thousand Net Income 250,000 200,000 150,000 2023年 100,000 2024年 2025年前三季 50,000 0 淨利 Total 2023 124,557 2024 200,097 2025 Q1-Q3 89,967 9
Slide 10: EPS in the past 3 years
EPS in the past 3 years EPS 2.00 1.50 2023年 1.00 2024年 2025年前三季 0.50 - EPS Total 2023 0.90 2024 1.45 2025 Q1-Q3 0.65 10
Slide 11: 03. Missioncare Healthy Taiwan
03. Missioncare 50 Healthy Taiwan 11
Slide 12: The New Era of Smart Healthcare: Hospital-at-Home
The New Era of Smart Healthcare: Bridging the Distance in Care Hospital-at-Home https://www.ankecare.com/article/2626-2023-07-13-17-02-21 Director-General of the National Health Insurance Administration, Shih Chung-liang: Expanding Home-Based Medical Care – Pilot Program for At-Home Hospitalizatio
Slide 13: Deep Collaboration Projects
Deep Collaboration Projects Using Missioncare General Hospital as the Core — Integrating and Sharing Resources to Build a Comprehensive Healthcare Network, Providing Holistic Health Services Integrated Medical Care Medical and Long-Term Care Integration Partner hospitals: Longtan Missioncare Hospita
Slide 14: Missioncare Smart Integrated Healthcare System
Missioncare Smart Integrated Healthcare System Ownership • Trust • Co-Creation Taiwan Biobank Health Data Home Care + Long- Dynamic Consent Term Care 3.0 Platform Devices and Systems Dr.PAD Institutions): (Residents / FaceHeart Data Data Input Output WinBody CoDoctor Others … Health Data & Measureme
Slide 15: YES Chain Pharmacy
WRF RATER REACH MN Missioncaro Ree e YES Chain Pharmacy 15 Mosdece HIGRRE Bamems Marne 8B ® i e cerceeercl Qj Beem Wea SA etennaea
Slide 16: 2025 YES Chain Development Highlights
2025 YES Chain Development Highlights • The Good Neighbor Pharmacy Alliance has reached its initial scale target, and the advantages of bulk purchasing are gradually emerging. In addition to tangible product sales, intangible offerings—such as advertising and cross- industry collaborations—have also
Slide 17: 2025 YES Chain Development Highlights (continued)
2025 YES Chain Development Highlights (continued) Pharmacy-Centric Thinking: The True Value of Joint Procurement From the perspective of a “pharmacy-centric mindset,”the value of joint procurement goes far beyond short-term “drug price differences.”Its true strategic significance lies in: • Building
Slide 18: Thank You for Listening
WRF RATER REACH MN Thank You for Listening